MedTrace Logo

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

NCT04798261 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-05-18

No results posted yet for this study

Summary

The objective of this study is to evaluate real world long-term functional outcomes, safety and performance of the Indigo Aspiration System for the treatment of pulmonary embolism (PE).

Conditions

Interventions

DEVICE

Indigo Aspiration System

Indigo Aspiration System

Sponsors & Collaborators

  • Penumbra Inc.

    lead INDUSTRY

Principal Investigators

  • John Moriarty, MD · University of California, Los Angeles

  • Aleksander Araszkiewicz, MD, PhD · Uniwersytecki Szpital Kliniczny w Poznaniu

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-25
Primary Completion
2026-12-31
Completion
2028-02-29
FDA Device
Yes

Countries

  • United States
  • Australia
  • Brazil
  • Germany
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04798261 on ClinicalTrials.gov